Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.
about
Nonalcoholic fatty liver diseaseThe diagnostic value of liver biopsyNonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Elevated serum aminotransferases secondary to rippling muscle disease.Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione.Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.Expression of fatty acid synthase in nonalcoholic fatty liver disease.Liver biopsy in a district general hospital: changes over two decadesAlanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulationNonalcoholic Fatty liver disease and obesity.Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study.The metabolic syndrome and nonalcoholic fatty liver disease in childrenPrevalence and etiology of abnormal liver tests in an adult population in Jilin, ChinaSpecific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.Non-alcoholic fatty liver disease: an overview.A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan.Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese menNonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.Normal serum alanine aminotransferase activity in uncomplicated obesity.Abnormal liver test results on routine screening. How to evaluate, when to refer for a biopsy.Best practice in primary care pathology: review 5.The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease.Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.Should nonalcoholic fatty liver disease be renamed?Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantationHydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosisCardiometabolic aspects of the polycystic ovary syndrome.Low yield of unselected testing in patients with acutely abnormal liver function testsAlleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASHMetabolic Syndrome and Serum Liver Enzymes in the General Chinese PopulationFast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.Mild Hypertransaminasemia in Primary Care.Nonalcoholic fatty liver disease: from clinical recognition to treatment.Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisNonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Therapeutic potential of green tea in nonalcoholic fatty liver disease.
P2860
Q24555779-9D256772-5A43-4853-A69E-DD8E51A44D6AQ24794230-C6E82ABE-F875-4439-B7D5-B1FEAB943DF7Q30435948-36A7B572-F203-449A-A08C-C44D2487DB72Q30540521-3CA468BC-697E-4AA2-BA77-C95794314414Q32049856-F1108A94-2C9D-4182-8C8D-8AAF83CDBBDCQ33836312-C31D8B3C-3414-4904-9F86-93D8599C6F37Q33954722-F255489A-4E56-463D-988F-A7E6D76B649FQ33962008-013E6357-0A94-46D3-BC25-5B7BF9D5E354Q34225745-B8FAF8AA-3C0C-495F-8E35-067A903E62ACQ34592729-59CA2F6F-4D5F-4A76-8A71-18665D00F9D4Q34605022-5E2B727C-AD37-4C25-9CA5-262DB27E3289Q34623218-2C12F92A-E878-46D0-916C-C3835D34EABCQ34778237-9F7F94B3-E646-4E91-AD4E-1C49347F6C02Q34779188-0D83D129-8FDC-43BB-9525-D62032023F2BQ34989773-D9F4BE1D-BF8A-4ED1-B239-300B45227BF9Q35009628-224CE5FB-E099-4664-B7B0-70D8E403B020Q35011355-5F445D8A-96AA-4C90-A3E0-B1A679349A72Q35125070-4A211007-56FC-4A4B-AC4D-B6CA019FADFCQ35588143-8AB111AA-1374-4A7A-A742-99A3E1F511D3Q35621628-884BC3A0-41C7-406C-BC08-9BD84A98EFF3Q35706654-B04F9401-6EFE-4EB4-A213-6EA9AB2A3169Q35770421-3B259C50-C3FE-4F75-9E76-5D5711863578Q35821209-D4BBC1EB-5DDF-4683-896B-CD5C61EE10E6Q35882617-664428DD-B5CB-43C7-B773-965A94855871Q35968720-726687F6-10B7-4A26-850E-9A55769F7121Q36141458-D9C3ADE1-2A9C-411A-8F5F-D8A0C46ACFB2Q36165357-01F8E6B0-E975-46D0-A406-7DADAF84764BQ36174863-EC191562-031C-4123-B668-AD5B72C1B12FQ36287892-00771189-BA37-4DAE-9CBA-F7481AE430E9Q36455025-904D2554-7E7D-4AD9-9F67-34C1C26E9C23Q36500315-5A25CE06-95EE-4AC1-A86F-B5CF8DCFBE6DQ36633937-2D6CF1C5-7B75-4B1E-9660-26A91B403E82Q36932311-42979976-7685-4100-BAF9-BED0AE2A2A33Q36952308-B923A822-A50B-40AC-8E95-1DD2DE52E406Q36962095-287186B2-64ED-4095-A3FB-780FAE482BD8Q37345907-29A6616D-32E8-4384-ABA6-1DEB82BB524DQ37392679-C56270DD-EB90-4FDC-B719-01AEA6D12892Q37581357-E4843EC8-EE40-4973-8175-F8C6E4A7E622Q37678998-67FFF9D9-84B8-42C9-AE44-3974C3C16864Q37973444-BEAEC758-615F-4F8B-8880-FA569790AB97
P2860
Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prospective evaluation of unex ...... atic and symptomatic patients.
@ast
Prospective evaluation of unex ...... atic and symptomatic patients.
@en
type
label
Prospective evaluation of unex ...... atic and symptomatic patients.
@ast
Prospective evaluation of unex ...... atic and symptomatic patients.
@en
prefLabel
Prospective evaluation of unex ...... atic and symptomatic patients.
@ast
Prospective evaluation of unex ...... atic and symptomatic patients.
@en
P2093
P2860
P1476
Prospective evaluation of unex ...... atic and symptomatic patients.
@en
P2093
Ben-Menachem T
Blumenkehl M
Vasudevan G
P2860
P304
P356
10.1111/J.1572-0241.1999.01451.X
P407
P577
1999-10-01T00:00:00Z